Related Experiment Video
Updated: Jan 31, 2026

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
Published on: October 29, 2019
Comparison of the Class Effects of Antisense Oligonucleotides in CByB6F1-Tg(HRAS)2Jic and CD-1 Mice
Tae-Won Kim1, Chris N Papagiannis2, Laura S Zwick2
11 Ionis Pharmaceutical, Carlsbad, California, USA.
Abstract:
The 6-month Tg.rasH2 mouse carcinogenicity model provides an acceptable alternative to the 2-year carcinogenicity study in CD-1 mice. However, key questions related to the use of this model for testing antisense oligonucleotides (ASOs) include the similarity in the biologic response between mouse strains and the feasibility of using data from the CD-1 mouse to set doses and dose schedules for a Tg.rasH2 carcinogenicity study. To evaluate the potential strain differences, four distinct 2'- O-(2-methoxyethyl) ASOs were administered to CByB6F1 (wild type), Tg.rasH2 (hemizygous), and CD-1 mice. There were no meaningful differences in clinical signs, body weight, food consumption, or serum chemistry and hematology parameters. Histopathology evaluation indicated little to no difference in the spectrum or magnitude of changes present. The cytokine/chemokine response was also not appreciably different between the strains. This was consistent with the similarity in ASO concentration in the liver between the mouse strains tested. As the class effects of the ASOs were not meaningfully different between CD-1, CByB6F1, or Tg.rasH2 mice, data from nonclinical studies in CD-1 mice can be used for dose selection and expectation of effect in the Tg.rasH2 mouse.
Insights
The Tg.rasH2 mouse model is a viable alternative for carcinogenicity studies of antisense oligonucleotides (ASOs). Data from CD-1 mice can inform dose selection for Tg.rasH2 studies due to similar biological responses across mouse strains.
Area of Science:
- Pharmacology and Toxicology
- Genetics and Genomics
- Preclinical Research
Background:
- The Tg.rasH2 mouse model offers a shorter alternative to traditional 2-year carcinogenicity studies.
- Key questions remain regarding strain-specific biological responses to antisense oligonucleotides (ASOs) in this model.
- Understanding these differences is crucial for effective dose selection and study design.
Purpose of the Study:
- To evaluate potential differences in biological responses to 2'- O-(2-methoxyethyl) antisense oligonucleotides (ASOs) across different mouse strains.
- To determine if data from CD-1 mice can be reliably used for dose setting in Tg.rasH2 carcinogenicity studies.
- To assess the utility of the Tg.rasH2 model as an alternative to the CD-1 mouse carcinogenicity study for ASOs.
Main Methods:
- Administration of four distinct 2'- O-(2-methoxyethyl) ASOs to CByB6F1 (wild type), Tg.rasH2 (hemizygous), and CD-1 mice.
- Comprehensive evaluation including clinical signs, body weight, food consumption, serum chemistry, hematology, and histopathology.
- Analysis of cytokine/chemokine profiles and liver ASO concentrations to compare strain-specific responses.
Main Results:
- No significant differences were observed in clinical signs, body weight, food consumption, or hematology/serum chemistry across the tested mouse strains.
- Histopathology revealed minimal differences in the type or severity of observed changes among CD-1, CByB6F1, and Tg.rasH2 mice.
- Cytokine/chemokine responses and liver ASO concentrations were comparable between strains, indicating similar systemic exposure and biological effects.
Conclusions:
- The biological responses to the tested ASOs were not meaningfully different between CD-1, CByB6F1, and Tg.rasH2 mice.
- Nonclinical data generated in CD-1 mice can be effectively utilized for dose selection and predicting effects in the Tg.rasH2 mouse model.
- This supports the Tg.rasH2 model's use as an acceptable alternative for ASO carcinogenicity testing, streamlining drug development.
More Related Videos
Related Concept Videos
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Drug Classes and Categories
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Multiple Comparison Tests
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Evolutionary Relationships through Genome Comparisons

